Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Profit progressed steadily due to the increase against the plan in the number of new users of the prescription online reception service in the Media Business, the addition of 2 new companies as consolidated subsidiaries, and continued cost optimization at each group company.
| Item | Details |
|---|---|
| Net Sales | ¥12,300 million → ¥12,330 million（0.2％） |
| Operating profit | ¥2,450 million → ¥2,681 million（9.4％） |
| Ordinary income | ¥2,400 million → ¥2,666 million（11.1％） |
| Profit attributable to owners of the parent | ¥2,690 million → ¥2,900 million（7.8％） |
| Net income per share | ¥236.79 → ¥253.08 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Previous fiscal year's consolidated results (fiscal year ended March 2025): consolidated net sales of ¥11,199 million, consolidated operating income of ¥1,953 million, consolidated ordinary income of ¥1,940 million, net income attributable to owners of the parent of ¥2,034 million, and consolidated earnings per share of ¥184.89 |
| Reason for the revision | Profit progressed steadily due to the increase against the plan in the number of new users of the prescription online reception service in the Media Business, the addition of 2 new companies as consolidated subsidiaries, and continued cost optimization at each group company. |
| Dividend forecast revision | The year-end dividend forecast was increased from ¥36.00 per share to ¥38.00 per share. The annual dividend forecast was increased from ¥36.00 per share to ¥38.00 per share. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profit progressed steadily as the number of new users of the prescription online reception service in the Media Business increased against the plan, 2 new companies were added as consolidated subsidiaries, and the Group continued to optimize costs at each group company. The dividend was increased based on the policy of maintaining stable dividends with a consolidated dividend payout ratio of approximately 15% and the upward revision to the earnings forecast.